Seegene Mexico
상단으로
Contáctenos

Not Available for sale in the United States

  • Real-time
    PCR
  • CE-IVD
    marked
  • COFEPRIS
    marked

Anyplex™ II
HPV28 Detection

Identificación y detección simultánea de 28 tipos de VPH (19 de alto riesgo y 9 de bajo riesgo)

Anyplex™Ⅱ HPV28 Detection detecta simultáneamente, diferencia y cuantifica 28 genotipos distintos de VPH (19 de alto riesgo y 9 de bajo riesgo) responsables por infecciones de cáncer cervical y/o infecciones de transmisión sexual. Basándose en las tecnologías TOCE™ y DPO™ propiedad de Seegene, este reporte multiplex se realiza con instrumentos PCR en tiempo real y provee información de genotipos de alta sensibilidad y especificidad de 28 tipos de VPH infectados en una sola reacción.

Características

  • PCR Multiplex en tiempo real

    Detección e identificación de 19 VPH de alto riesgo y 9 VPH de bajo riesgo en una sola reacción

  • Potente rendimiento con tecnología única

    Multiplex PCR con alta sensibilidad y especificidad al aplicar tecnologías DPO™ TOCE™

  • Analizador de datos automáticos

    Interpretación de datos automática y LIS entrelazado con Pantalla Seegene

  • Reporte informativo

    Asistente de tratamiento apropiado y manejo para co-infección

  • Validación de proceso entero

    Validación de proceso entero desde extracción a PCR por control de proceso entero

  • Monitoreo útil

    Herramienta útil para vigilancia y control de infecciones

  • Flujo de trabajo amigable al usuario

    Flujo de trabajo conveniente usando la plataforma uno automatizada de Seegene

  • Análisis cuantitativo

    Análisis cuantitativo por CMTA cíclico

  • Sistema UDG

    Utilización del sistema UDG para prevenir contaminación remanente

  • Analitos

    19 High-risk HPV types
    • Human Papillomavirus 16 (HPV 16)
    • Human Papillomavirus 18 (HPV 18)
    • Human Papillomavirus 26 (HPV 26)
    • Human Papillomavirus 31 (HPV 31)
    • Human Papillomavirus 33 (HPV 33)
    • Human Papillomavirus 35 (HPV 35)
    • Human Papillomavirus 39 (HPV 39)
    • Human Papillomavirus 45 (HPV 45)
    • Human Papillomavirus 51 (HPV 51)
    • Human Papillomavirus 52 (HPV 52)
    • Human Papillomavirus 53 (HPV 53)
    • Human Papillomavirus 56 (HPV 56)
    • Human Papillomavirus 58 (HPV 58)
    • Human Papillomavirus 59 (HPV 59)
    • Human Papillomavirus 66 (HPV 66)
    • Human Papillomavirus 68 (HPV 68)
    • Human Papillomavirus 69 (HPV 69)
    • Human Papillomavirus 73 (HPV 73)
    • Human Papillomavirus 82 (HPV 82)
    • Internal Control (IC)
  • 9 Low-risk HPV types
    • Human Papillomavirus 11 (HPV 11)
    • Human Papillomavirus 40 (HPV 40)
    • Human Papillomavirus 42 (HPV 42)
    • Human Papillomavirus 43 (HPV 43)
    • Human Papillomavirus 44 (HPV 44)
    • Human Papillomavirus 54 (HPV 54)
    • Human Papillomavirus 6 (HPV 6)
    • Human Papillomavirus 61 (HPV 61)
    • Human Papillomavirus 70 (HPV 70)
    • Internal Control (IC)
  • Especímenes

    • Liquid based cytology (e.g., ThinPrep® and Surepath™)
    • Cervical swab
  • Información de pedidos

    Product
    Cat No. / Size
    Anyplex™ II HPV28 Detection
    HP7S00X / 100 rxns

Resultado

El resultado representa co-infecciones en las que VPH 16 es alto (+++) en el canal HEX, VPH 52 es alto (+++) en el canal Cal Red 610, VPH 35, 61 son altas (+++) en el canal Quasar 670 y VPH 40 es intermedia (++) en el canal Quasar 705 .

Publicación

- Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment

- Distribution of HPV Genotypes in Patients with a Diagnosis of Anal Cancer in an Italian Region

- Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening

- Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey

- Evaluation of the Anyplex II HPV28 Assay in the Detection of Human Papillomavirus in Archival Samples of Oropharyngeal Carcinomas

- Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study

- Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg

- A Retrospective Study about the Impact of Switching from Nested PCR to Multiplex Real-Time PCR on the Distribution of Human papillomavirus (HPV) Genotypes 

- High Prevalence of Anal and Oral High-Risk Human Papillomavirus in Human Immunodeficiency Virus–Uninfected French Men Who Have Sex With Men and Use Preexposure Prophylaxis

- Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population

- Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features

- High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N’Djamena, Chad

- Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia

- Mutational landscape and intra‑host diversity of human papillomavirus type 16 long control region and E6 variants in cervical samples

- Importance of High-Risk Human Papillomavirus Infection Detection in Female Renal Transplant Recipients in the First Year after Transplantation

- Esophageal squamous cell carcinomas in a Malaysian cohort show a lack of association with human papillomavirus

- Prevalence of human papillomavirus and bacteria as sexually transmitted infections in symptomatic and asymptomatic women

- High Burden of Human Papillomavirus Infection in Madagascar: Comparison With Other Sexually Transmitted Infections

- Prevalence of Vaccine Type Infections in Vaccinated and Non-Vaccinated Young Women: HPV-IMPACT, a Self-Sampling Study

- Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016

- Prevalence of Human Papillomavirus in Laryngeal Squamous Cell Carcinoma in Azerbaijan Population

- Esophageal squamous cell carcinoma in a Malaysian cohort shows a lack of association with human papillomavirus

- Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer

- Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic

- A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix

- Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016

- High-grade anal intraepithelial neoplasia (AIN) is associated with HIV-1 RNA rectal shedding in virologically suppressed MSM

- Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy

- Prevalence of Sexually Transmitted Infections among Married Women in Rural Nepal

- Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies

- Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions

- Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

- Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings

- Chlamydia trachomatis and HPV co- infections in HIV negative men from a multi-ethnic area of Northern Italy at high prevalence of cervical malignancies

- Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings

- Type Distribution of Human Papillomavirus in Genital Warts of Korean Men

- Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala

- Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection

- Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus

- HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples

- Comparison of the Analytical and Clinical Performance of Five Tests for the Detection of Human Papillomavirus Genital Infection

- Prevalence, genotype distribution and temporal dynamics of human papillomavirus infection in a population in southern Italy

- Prevalence of human papillomavirus and bacteria as sexually transmitted infections in symptomatic and asymptomatic women

- Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala

- HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples

- Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea

- HPV Genotyping from the high risk mRNA Aptima assay- a direct approach using DNA from Aptima sample tubes

- Use of swabs for dry collection of self samples to detect human papillomavirus among Malagasy women

- Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas

- Use of swabs for dry collection of selfsamples to detect human papillomavirus among Malagasy women

- Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas

- HPV Genotyping from the high risk mRNA Aptima assay- a direct approach using DNA from Aptima sample tubes

- No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population

- Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus

- No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population

- Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus

- Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples

- Prevalence of human papillomavirus infection among women in rural Nepal

- Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus

- Prevalence of human papillomavirus infection among women in rural Nepal

- Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer

- Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea

- Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer

- Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea

- Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus

- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

- Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea

- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

- Clincal validation of the Anyplex II HPV HR Detection for the Cervical Cancer Screening

- Evaluation of HPV Genotyping Assays for Archival Clinical Samples

- Performance evaluation of Anyplex™II HPV28 detection kit in a routine diagnostic setting: Comparison with the HPV Sign® Genotyping Test

- Type-specific persistence or regression of human papillomavirus genotypes in women with cervical intraepithelial neoplasia 1: A prospective cohort study

- Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case–control study in Kumasi, Ghana

- Evaluation of HPV genotyping assays for archival clincal smaples

- Updating the PGMY primers and probes for improved detection of HPV68a: validation of version 2 of the PGMY-CHUV assay

- A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology

- Human papillomavirus genotyping: comparison of the Seegene AnyplexTM II HPV28 with the PGMY-CHUV assay

- High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection

- A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology

- Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection

- A case of HPV-53-related cervical cancer in an elderly patient

- Prevalence of Human Papillomavirus Infection and Genotype Distribution Determined by the Cyclic-Catcher Melting Temperature Analysis in Korean medical checkup population

- Comparative Evaluation of the HPV28 Detection and HPV DNA Chip Test for Detecting and Genotyping Human Papillomaviruses